ConductScience.org, home

Paper · 34945755

Economic Evaluation of Universal Lynch Syndrome Screening Protocols among Newly Diagnosed Patients with Colorectal Cancer.

Hao J and 10 others. J Pers Med, 2021. Cited by 14 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Economic Evaluation of Universal Lynch Syndrome Screening Protocols among Newly Diagnosed Patients with Colorectal Cancer. Papers, record 34945755. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34945755

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Economic Evaluation of Universal Lynch Syndrome Screening Protocols among Newly Diagnosed Patients with Colorectal Cancer.
PubMed
Journal
J Pers Med
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.88
iCite
Revised in PubMed
2022-03-29
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hao JJinghttps://orcid.org/0000-0001-9332-3842
2Hassen DDina
3Gudgeon JMJames M
4Snyder SRSusan R
5Hampel HHeather
6Williams MSMarc Shttps://orcid.org/0000-0001-6165-8701
7Sharaf RNRavi N
8Lu CYChristine Y
9Williams JLJanet Lhttps://orcid.org/0000-0002-4604-3933
10Schlieder VVictoria

1 to 10 of 11Source PubMed

See all 11 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA211723NCI NIH HHSUnited StatesR01CA211723PubMed and NIH
R01CA211723NCI NIH HHSUnited StatesR01CA211723PubMed and NIH

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126,938,782Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.Genet Med2016https://conductscience.org/library/papers/26938782PubMed
222,658,618ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.J Mol Diagn2012https://conductscience.org/library/papers/22658618PubMed
329,300,371Which Lynch syndrome screening programs could be implemented in the "real world"? A systematic review of economic evaluations.Genet Med2018https://conductscience.org/library/papers/29300371PubMed
426,028,255PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.N Engl J Med2015https://conductscience.org/library/papers/26028255PubMed
531,130,287Is immunohistochemistry-based screening for Lynch syndrome in endometrial cancer effective? The consent's the thing.Gynecol Oncol2019https://conductscience.org/library/papers/31130287PubMed
69,041,175Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.Cancer Res1997https://conductscience.org/library/papers/9041175PubMed
715,544,708Generalisability in economic evaluation studies in healthcare: a review and case studies.Health Technol Assess2004https://conductscience.org/library/papers/15544708PubMed
831,189,173Generic Cost-Effectiveness Models: A Proof of Concept of a Tool for Informed Decision-Making for Public Health Precision Medicine.Public Health Genomics2018https://conductscience.org/library/papers/31189173PubMed
918,809,606Feasibility of screening for Lynch syndrome among patients with colorectal cancer.J Clin Oncol2008https://conductscience.org/library/papers/18809606PubMed
1020,084,010The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.Genet Med2010https://conductscience.org/library/papers/20084010PubMed

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42,958,100
A novel predictive model for DNA mismatch repair deficient colorectal carcinoma for cost-effective MMR testing in low-resource settings: HERALD-MMR (Histological Evaluation and Risk Assessment using Local Demographics for Mismatch Repair).
BMC Cancer2026https://conductscience.org/library/papers/42958100PubMed
42,649,864Universal Tumor Screening in Colorectal Cancer: Role of MMR Immunohistochemistry for Lynch Syndrome and Early-Onset CRC.Cancers (Basel)2026https://conductscience.org/library/papers/42649864PubMed
40,978,308Hereditary Nonpolyposis Colon Cancer (Lynch Syndrome): An Emerging Public Health Concern.Health Sci Rep2025https://conductscience.org/library/papers/40978308PubMed
40,315,972Cost-effectiveness of Lynch Syndrome Screening in Colorectal Cancer: Universal Germline vs Sequential Screening.Clin Gastroenterol Hepatol2025https://conductscience.org/library/papers/40315972PubMed
40,172,779The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review.Appl Health Econ Health Policy2025https://conductscience.org/library/papers/40172779PubMed
40,010,417Cost-Effectiveness of Lynch Syndrome Identification Strategies in Individuals With Colorectal Cancer and the Impact on At-Risk Relatives.Clin Gastroenterol Hepatol2025https://conductscience.org/library/papers/40010417PubMed
37,978,552"Go ahead and screen" - advice to healthcare systems for routine lynch syndrome screening from interviews with newly diagnosed colorectal cancer patients.Hered Cancer Clin Pract2023https://conductscience.org/library/papers/37978552PubMed
37,897,815Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey.JCO Precis Oncol2023https://conductscience.org/library/papers/37897815PubMed
37,743,058Comparison of immediate germline sequencing and multi-step screening for Lynch syndrome detection in high-risk endometrial and colorectal cancer patients.J Gynecol Oncol2024https://conductscience.org/library/papers/37743058PubMed
37,098,602A picture is worth a thousand words: advancing the use of visualization tools in implementation science through process mapping and matrix heat mapping.Implement Sci Commun2023https://conductscience.org/library/papers/37098602PubMed

1 to 10 of 11

See all 11 cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34945755

GET https://conductscience.org/api/papers/v1/34945755/references?page=2